3) It is probable that haemodynamic factors as well are responsible for graft failure. In this respect the geometry of the graft should be changed in order to improve its durability.
Living autologous tissue grafts Because there are many unknown factors in the long-term fate and function of preserved grafts, we have turned our attention towards the use of living autologous tissue (Ionescu and Ross, I969; Ionescu and Deac, I970). Senning (1970) has been using free fascia lata grafts for aortic valve reconstruction or replacement since I962 with good results. Ross (I967b) has beenusingover the past three years the patient's own pulmonary valve for aortic or mitral valve replacement and the results are superior to those obtained with homografts.
We have developed a frame-supported autologous fascia lata graft for use in both the atrioventricular and the aortic positions. Since April I969 82 patients (7 to 64 years old) had the mitral valve alone or in combination with other valves replaced with 98 fascial grafts. Except for three, all patients were in class III or IV (N.Y.H.A.) preoperatively. In this group of patients there were 13I associated abnormalities and 25 of them had had previous heart valve surgery. In addition I4 other cardiac procedures were performed at the time of valve replacement. There were I0 hospital deaths (12.2%), none of them being related to the graft per se.
Three patients succumbed after the operative period, two from subacute bacterial endocarditis at 2 and 3 months respectively; one death presumed to be from arrhythmia occurred 2 months postoperatively.
There were a few late complications related to the valve grafts in the 69 survivors. Three patients, with mitral replacement, developed a systolic murmur at the apex (grade i/6), while two others have a grade 2/6 systolic murmur. All five are in a very good clinical condition and four of them are considered to be improved after haemodynamic studies. Radiographs show a reduction in their heart size. The murmurs do not seem to be increasing in intensity with the passage of time.
The cause and mechanism of production of the murmurs is not known, but they could only be produced by regurgitation through or around the graft.
A patient who did not improve after surgery was reoperated upon six months after mitral valve replacement. It appears probable that if the fibroblasts continue to live they will 'service' the matrix and therefore preserve the integrity of the transplanted tissue (Gallie and Le Mesurier, 192I, I922, 1948) .
The clinical use of fascia lata for aortic valve repair or replacement (Senning, I970) has shown good results up to eight years postoperatively. The structure and function of fascia are well preserved, although definite proof concerning the viability of the fibroblast has not yet been obtained.
Our clinical experience with frame-mouned fascial grafts has shown that in a different haemodynaniic situation in the mitral area these grafts perform satisfactorily more than one year after implantation (Ionescu et al., 1970) .
Criteria
There are several criteria to be considered when a heart valve substitute is evaluated. The frame-mounted autologous fascia lata grafts fulfil very well most of them.
The advantages of using biological tissue have already been stressed. Fascia, being transplanted as an autologous graft, can be transferred to the new site in a viable state. Whether the viability of the entire structure will be maintained for an extended period of time remains to be seen.
The technique of making the grafts at the time of surgery is a reproducible one requiring not more than the usual surgical skill.
The fascial grafts are available in all necessary sizes, being tailored individually for each case.
The surgical insertion is as simple and as rapid as for a prosthetic valve.
The flow characteristics are almost identical to those of a natural aortic valve and the haemodynamic performance has proved itself to be very satisfactory.
Fascial valves seem to be more prone to infection than other valves. With special care this type of complication can be avoided.
Thromboembolic complications are virtually eliminated by the use of fascial grafts even without anticoagulants.
The durability of fascia lata seems to satisfy the requirements of a heart valve. In the aortic position there is good evidence of continued function over a period of eight years. In the mitral position our follow-up is too short to draw any conclusions. The initial results over more than one year are very good.
This method ofheart valve replacement will be evaluated over an extended period of time. Its clinical value depends on the ultimate fate and long-term function of the fascial tissue.
